Work

Should we Address Biochemical Recurrence of Prostate Cancer as Soon as Possible? Against

Year: 2018

Type: article

Abstract: The advent of enhanced imaging in prostate cancer has resulted in recurrent disease being identified earlier. This has led to an increase in the number of patients undergoing intervention at this early stage. There remains, however, a paucity of level one evidence to advise on the optimal management of this heterogenous group, with a significant number of patients experiencing biochemical relapse unlikely to die of metastatic prostate cancer. More work is needed to define those who do and do not require intervention, to avoid doing harm to an often elderly population.

Source: European Oncology & Haematology

DOI: 10.17925/eoh.2018.14.1.14

Authors: Robert Chandler, Antonella Petremolo, Pasquale Rescigno, Johann de Bono

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Federico II University Hospital, University of Naples Federico II

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2804928400

FWCI:

Cites: 12

Cited by:

Related to: 10